Sihuan Pharmaceutical Holdings Group (460)
Sihuan Pharmaceutical Holdings Group Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products. It focuses in the field of cardio-cerebral vascular system, nervous system, metabolism, anti-infective, and oncology. It offers prescription drugs in different formulations and dosages. The company was founded by Feng Sheng Che, and Wei Cheng Guo in 2001 and is headquartered in Hainan, China.
|Market Price at 20-11-2017
|Price to Earnings Ratio
|Return on Equity (ROE)
Blog posts that reference Sihuan Pharmaceutical Holdings Group:
Thursday, January 30, 2014
Reports for around 300 global stocks flowed through Skaffold during January, including Apple, Microsoft, Procter and Gamble, AT&T, Facebook, Intel, The Boeing Company, eBay, Nike, Caterpillar, Starbucks, Kimberly Clark, Yahoo!, Motorola, Xerox, Oshkosh, The Bank of Nova Scotia, Metro Inc, Prada, Singapore Exchange, PZ Cussons and SGS Societe Generale de Surveillance.
Exclusively for Skaffold members, we’ve put together a list of companies whose latest financial results are now available in Skaffold, including updated Skaffold Scores and Safety Margins.
Tuesday, January 21, 2014
Buying top-notch stocks at below their true value is the hallmark of successful value investors.
For the past two years Money magazine has asked Skaffold.com to name the Top 50 undervalued stocks, including five standouts.
Skaffold’s 2013 top stocks produced exceptional results and outperformed the All Ords Accumulation Index, as our 2012 portfolio had done the previous year. Assuming you invested $50,000 equally across the 2012 Top 5 stocks on 10 January 2012, sold on 11 January 2013, then purchased the 2013 Top 5 stocks, and sold on 10 January 2014, your 2 year return, including capital gains and income, would be 21.3% p.a.. Over the same period the All Ords Accumulation Index returned 17.5% p.a.. Skaffold’s Top Stocks outperformed the Index by 3.8% p.a.. That equates to $4,560 more profit in your pocket.
On 6 February 2014 Money magazine will hit the newsstands, unveiling Skaffold’s top stocks for 2014, which for the first time includes global shares.
Until then, here is a rundown on Skaffold’s 2012 and 2013 Money portfolios, and how the stocks stack up in Skaffold today.
Wednesday, April 17, 2013
Last night Skaffold’s General Manager Chris Batchelor appeared on the Sky Business Channel with Peter Switzer. Chris chatted with Peter about the recent research Skaffold completed on global investing trends.
Friday, March 22, 2013
In a rising market the thought of selling shares may seem a little odd. “Why would I sell when the value of my portfolio increases every day?” you ask.
It’s easy to get caught up in the momentum of impressive performance, meanwhile ignoring the poor and worsening economics of the business. Share prices cannot outperform business performance indefinitely and stockmarkets do not continue to rise. After a while, something has to give.
That’s why understanding when you should sell shares is crucial.